share_log

Hypera S.A. (OTCMKTS:HYPMY) Short Interest Update

Hypera S.A. (OTCMKTS:HYPMY) Short Interest Update

Hypera S.A.(场外交易代码:HYPMY)空头股数更新
kopsource ·  2022/07/15 21:51

Hypera S.A. (OTCMKTS:HYPMY – Get Rating) was the recipient of a significant decline in short interest in June. As of June 30th, there was short interest totalling 800 shares, a decline of 75.0% from the June 15th total of 3,200 shares. Based on an average daily trading volume, of 14,000 shares, the short-interest ratio is currently 0.1 days.

Hypera S.A.(场外交易代码:HYPMY-GET Rating)是6月份空头股数股价大幅下降的接收方。截至6月30日,空头股数共有800股,较6月15日的3200股下降了75.0%。以日均成交量1.4万股计算,目前短息比为0.1天。

Hypera Stock Performance

Hypera股票表现

HYPMY stock traded up $0.18 during trading on Friday, reaching $7.36. 2,840 shares of the company were exchanged, compared to its average volume of 16,894. Hypera has a 52-week low of $4.63 and a 52-week high of $8.89. The company has a market cap of $4.66 billion, a P/E ratio of 17.52 and a beta of 0.77. The stock's 50 day moving average price is $7.59 and its 200 day moving average price is $6.96.

在周五的交易中,HYPMY的股票上涨了0.18美元,达到7.36美元。该公司成交量为2,840股,而其平均成交量为16,894股。Hypera的52周低点为4.63美元,52周高点为8.89美元。该公司市值为46.6亿美元,市盈率为17.52倍,贝塔系数为0.77。该股的50日移动均线价格为7.59美元,200日移动均线价格为6.96美元。

Get
到达
Hypera
金丝桃组
alerts:
警报:

About Hypera

关于Hypera

(Get Rating)

(获取评级)

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA在巴西作为一家制药公司运营。它提供的处方药有Adacne、Addera、Apri、AmpliumG、请、赛莱他明、Celstone、Celstone Soluspana、Cizax、DECPRAX、衍生CMicro、Micro Drift、Dermol Fusid、Digedrat、双丙胺、双丙沙星、双丙松、双丙松、Emprol XR、Flow、Garasone、Halobx、Lipanon、Moon、Lydian、Macrodantin、MaxSulid、MilGamma、Mioflex-A、Nesina、Novotram、oximax、peridid、Perida混悬剂、Predsim、Pressaliv、Quadriderm、Rizi、Rizi、Softalm、acrotz、tinodin、umma和velunid品牌。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on Hypera (HYPMY)
  • MarketBeat: Week in Review 7/11 – 7/15
  • Is Coupang's Stock On The Verge Of A Turnaround?
  • Should You Have These Two Banks In Your Portfolio?
  • Verint Systems Stock is a Customer Engagement Play
  • Why Shopify Stock Split...And is as Shoppable as Ever
  • 免费获取StockNews.com关于Hypera的研究报告(HYPMY)
  • MarketBeat:回顾一周7/11-7/15
  • Coupang的股票即将翻身吗?
  • 你的投资组合中应该有这两家银行吗?
  • Verint Systems Stock是一场客户互动活动
  • 为什么Shopify股票拆分...并一如既往地适合购物

Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.

接受Hypera Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Hypera和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发